← FDA Drug Approvals (Drugs@FDA)
ZIPRASIDONE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2013-10-10
Drug application
- FDA Application #
ANDA202395- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ZIPRASIDONE HYDROCHLORIDE
- Generic name
- Ziprasidone Hydrochloride
- Active ingredients
- ZIPRASIDONE HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2013-10-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown